TegoScience Inc. (KOSDAQ:191420)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,040
+40 (0.27%)
At close: Jan 28, 2026
-9.29%
Market Cap118.50B
Revenue (ttm)6.15B -11.2%
Net Income-3.25B
EPS-406.28
Shares Out8.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,327
Average Volume16,815
Open15,000
Previous Close15,000
Day's Range14,740 - 15,220
52-Week Range13,000 - 20,500
Beta1.03
RSI49.13
Earnings DateNov 14, 2025

About TegoScience

TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics qualit... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 191420
Full Company Profile

Financial Performance

Financial Statements